Insurance and regulatory

FDA Drug Shortage List

The vocabulary of getting a claim paid, of FDA enforcement, and of what on-label and off-label really mean.

Definition

FDA's public register of medicines in short supply. It is the hinge of this entire market: while semaglutide and tirzepatide sat on it, compounding them at scale was lawful under the shortage exemption. Both came off in late 2024, and the compounding that continues now rests on narrower ground.

Compounded GLP-1 price movement (12-month analysis)

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under Insurance and regulatory

Where the evidence lives